Home › Research › Lewy body dementia
Lewy Body Dementia Research in Latin America: A Scoping Review
Carlos Alberto Cano, Salomón Salazar‐Londoño, Felipe Botero Rodríguez, Salomón Páez‐García, Salomón Giraldo, José Manuel Santacruz Escudero, Dag Aarsland, Miguel Germán Borda et al.. Movement Disorders Clinical Practice, 2025-04-21
Topic: Risk, prevention and care in population studies
Plain-language summary
Of the 1388 studies identified, 70 met the inclusion criteria for this review. Among them, 63 were cross-sectional studies, three were cohort studies, two followed a case-control methodology, and only two were non-randomized clinical trials. These studies primarily examined clinical manifestations, risk factors, neuropsychiatric and non-motor symptoms, as well as cognitive impairment and its assessment in LBD within LA. Regarding geographical distribution, 52 studies were conducted in Brazil, seven in Argentina, the rest in Peru, Mexico, Colombia, Cuba, and Chile. LBD research in LA is underrepresented, with most studies being cross-sectional, few utilizing a longitudinal design, and only two clinical trials, both of which lack rigorous methodology. Challenges include weak study designs, high heterogeneity, limited trials, and unclear differentiation within the LBD spectrum. Addressing these gaps requires increasing awareness, strengthening research capacity, securing funding, and fostering international collaboration.
What this study adds
Evidence grade: High
This is a follow-up (cohort) study. This scoping review found that Lewy body dementia research in Latin America is underrepresented, with most studies being cross-sectional and only two clinical trials that lack rigorous methodology. It is about research gaps, not about treating, curing or preventing dementia.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Cano, C. A., Salazar‐Londoño, S., Rodríguez, F. B., Páez‐García, S., Giraldo, S., Escudero, J. M. S., et al. (2025). Lewy Body Dementia Research in Latin America: A Scoping Review. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70059
Vancouver
Cano CA, Salazar‐Londoño S, Rodríguez FB, Páez‐García S, Giraldo S, Escudero JMS, et al. Lewy Body Dementia Research in Latin America: A Scoping Review. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70059. PMID: 40256832.
BibTeX
@article{cano2025-40256832,
author = {Cano, Carlos Alberto and Salazar‐Londoño, Salomón and Rodríguez, Felipe Botero and Páez‐García, Salomón and Giraldo, Salomón and Escudero, José Manuel Santacruz and Aarsland, Dag and Borda, Miguel Germán and others},
title = {{Lewy Body Dementia Research in Latin America: A Scoping Review}},
journal = {Movement Disorders Clinical Practice},
year = {2025},
doi = {10.1002/mdc3.70059},
pmid = {40256832},
url = {https://doi.org/10.1002/mdc3.70059}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Of the 1388 studies identified, 70 met the inclusion criteria for this review.
- Among them, 63 were cross-sectional studies, three were cohort studies, two followed a case-control methodology, and only two were non-randomized clinical trials.
- These studies primarily examined clinical manifestations, risk factors, neuropsychiatric and non-motor symptoms, as well as cognitive impairment and its assessment in LBD within LA.
- Regarding geographical distribution, 52 studies were conducted in Brazil, seven in Argentina, the rest in Peru, Mexico, Colombia, Cuba, and Chile.
- LBD research in LA is underrepresented, with most studies being cross-sectional, few utilizing a longitudinal design, and only two clinical trials, both of which lack rigorous methodology.
Why it matters
This scoping review found that Lewy body dementia research in Latin America is underrepresented, with most studies being cross-sectional and only two clinical trials that lack rigorous methodology. It is about research gaps, not about treating, curing or preventing dementia.
Study details
- Study designcohort study
- Evidence strengthHigh
How this study scored 47/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 45 of the 96 points we could judge it on, which is 47 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Movement Disorders Clinical Practice) |
| Journal's citation record | 0 / 4 | Movement Disorders Clinical Practice: journal h-index 59 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | 1 / 3 | King's College London: institution h-index 1,348 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 5 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40256832) |
| Free to read | 2 / 2 | Free to read |
| Points | 45 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 45 of the 96 points we could judge it on is 47 out of 100. |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/mdc3.70059
- PubMed: 40256832
- Original source →
- Free full text: Movement Disorders Clinical Practice →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Lewy body dementia from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.